ATP11A, which is a member of class 6 of P4-ATPases family is a possible negative predictive marker for metachronous metastasis in colorectal cancer patients [47] and may confer resistance to cancer treatment with farnesyltransferase inhibitors [48]. This evidence concerns the gene ATP11A and colorectal cancer.